|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Prelude Therapeutics (NASDAQ: PRLD) through any online brokerage.
The latest price target for Prelude Therapeutics (NASDAQ: PRLD) was reported by HC Wainwright & Co. on April 26, 2021. The analyst firm set a price target for 62.00 expecting PRLD to rise to within 12 months (a possible 99.87% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $31.02 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Prelude Therapeutics.
There is no upcoming split for Prelude Therapeutics.
Prelude Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.